Leiden University Medical Center
Leiden, South Holland, 2333 ZA, Netherlands
NCT Number: NCT05977205
Diabetes mellitus is a chronic disease characterized by the inability of the body to maintain normoglycemia. Treatment of diabetes relies mostly on diabetes self-management, requiring a large investment of time and energy on a daily basis. Psychological wellbeing, behavioral patterns and social context play a major role in diabetes self-management and glycemic control. Social isolation behavior (self-quarantining) may impact glycemic control by influencing daily routines, therapy adherence, physical activity, and self-measurement and eating behaviors. Therefore, a period of nationwide self-quarantine, such as during the lockdown issued during the COVID-19 outbreak in the Netherlands, may have a large effect on glycemic control in patients with diabetes.
In this observational cross sectional study, we aim to assess the impact of long-term self-quarantine on glycemic control, diabetes self-management and distress in patients with type 1 and type 2 diabetes mellitus.
A specific subgroup of patients with T1D are those with complicated diabetes who have received a pancreas or islet transplantation and use immunosuppression, having multiple risk factors for severe COVID-19. The impact of lockdown strategies on mental and physical health is expectedly even greater in patients at even higher risk for severe COVID-19. We therefore additionally investigated differences in behavioral, mental and physical implications of a nationwide lockdown on patients with type 1 diabetes with and without islet or pancreas transplantation.
Measurements will be performed during the lockdown period. Patients will be asked to perform a fingerprick HbA1c measurement once, sent back to the LUMC by mail. Data from continuous or flash glucose monitoring devices will be collected according to standard clinical practice. Furthermore, patients will be asked to fill out an online questionnaire once on diabetes self-management behavior, well-being and distress, along with questions about health status, level of education, medication use, employment, social situation and the impact of self-quarantine on daily routines. In this questionnaire, we ask patients to compare certain aspects of their life (e.g. anxiety, stress, weight, physical activity, glycemic control) at the time of the lockdown to before the lockdown. Data on demographics, type of diabetes, weight, BMI and HbA1c prior to the COVID-19 outbreak will be derived from the patient's electronic health file.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Leiden, South Holland, 2333 ZA, Netherlands
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Not applicable, no interventions, observational study
Time frame: HbA1c measurement during lockdown (8 - 11 weeks after the start of the lockdown (March 15th 2020)) compared to last measurement before lockdown (last known measurement before March 15th 2020)
HbA1c (mmol/mol Hb)
Time frame: 2 week period during lockdown compared to 2 week period before lockdown
Continuous Glucose Measurement parameters (time in range, time above range, time below range)
Time frame: PSS During lockdown + self-comparison change to before lockdown (questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Perceived Stress Scale (PSS) + self-reported change in stress during lockdown compared to before lockdown
Time frame: Questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Self-reported change in anxiety during lockdown compared to before lockdown
Time frame: Questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Self-reported weight change during lockdown compared to before lockdown
Time frame: Questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Self-reported change in physical activity during lockdown compared to before lockdown
Time frame: Questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Self-reported change in difficulty with glycemic control and insulin requirements during lockdown compared to before lockdown
Time frame: Questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Self-reported social isolation behaviour during lockdown
Time frame: Questionnaire filled in between 8 - 11 weeks after the start of the lockdown (March 15th 2020))
Fear of contracting COVID-19, scored using a Visual Analogue Scale (1-10), during lockdown
Leiden University Medical Center
Other
The Impact of Self-quarantining on Glycemic Control, Diabetes Self-management and Distress During the Coronavirus Outbreak
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229718
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT07403565
Autoimmune Diseases, Diabetes Mellitus
Beijing, Beijing Municipality, China
View Trial DetailsNCT06418880
Autoimmune Diseases, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsNCT05893797
Autoimmune Diseases, Diabetes Mellitus
Strasbourg, Alsace, France
View Trial Details